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Abstract: Cardiac muscle necrosis is associated with inflammatory cascade that clears the infarct from dead 
cells and matrix debris, and then replaces the damaged tissue with scar, through three overlapping phases: the 
inflammatory phase, the proliferative phase and the maturation phase.
Western blotting, laser confocal microscopy, Raman microscopy are valuable tools for studying the inflamma-
tory response following myocardial infarction both humoral and cellular phase, allowing the identification and 
semiquantitative analysis of proteins produced during the inflammatory cascade activation and the topographical distribu-
tion and expression of proteins and cells involved in myocardial inflammation. Confocal laser scanning microscopy 
(CLSM) is a relatively new technique for microscopic imaging, that allows greater resolution, optical sectioning of the 
sample and three-dimensional reconstruction of the same sample. Western blotting used to detect the presence of a spe-
cific protein with antibody-antigen interaction in the midst of a complex protein mixture extracted from cells, produced 
semi-quantitative data quite easy to interpret. Confocal Raman microscopy combines the three-dimensional optical resolu-
tion of confocal microscopy and the sensitivity to molecular vibrations, which characterizes Raman spectroscopy.
The combined use of western blotting and confocal microscope allows detecting the presence of proteins in the sample 
and trying to observe the exact location within the tissue, or the topographical distribution of the same. Once demonstrated 
the presence of proteins (cytokines, chemokines, etc.) is important to know the topographical distribution, obtaining in this 
way additional information regarding the extension of the inflammatory process in function of the time stayed from the 
time of myocardial infarction. These methods may be useful to study and define the expression of a wide range of in-
flammatory mediators at several different timepoints providing a more detailed analysis of the time course of the infarct. 
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INTRODUCTION 
 Once myocardial infarction occurs, infracted myocar-
dium undergoes a progressive sequence of changes consist-
ing of loss of contraction of a myocardial region (atonic 
death), myocellular stretching, shown by prominent I bands 
demonstrated electron microscopically [1] and by histology 
[2], that represents the first functional change following a 
myocardial infarct followed by inflammation and replace-
ment with scar tissue [3, 4].
 The earliest histological signs are visible within 30 min 
of infarct onset and consist of mild myofiber eosinophilia 
and elongation of sarcomeres and nuclei. The latter show 
peripheral chromatin clumping followed by a progressive 
fading with their disappearance within 10 to 15 days. Other 
typical changes occur after 6 to 8 h with a margination of 
polymorphonuclear (PMN) leukocytes in vessels at the pe-
riphery of the necrotic zone followed by an infiltration of 
these elements, without fibrin or hemorrhage, into the dead  
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tissue. A crowd of PMN is visible along a line between infil-
trated and non-infiltrated necrotic myocardium in large areas 
of necrosis. PMNs disappear by lysis within 5 to 7 days, ac-
cording to the size of the necrosis, without evidence of re-
lated myocellular change. Again at the periphery of the ne-
crotic myocardium, a repair process starts at 1 week by 
macrophagic digestion of tissue within the sarcolemmal 
sheets and progressive collagenization to form a dense scar.  
 In general, no pathognomonic histologic sign is visible 
within 6 to 8 h of survival after onset when PMN infiltration 
starts [4].
 However a large number of studies, both human and 
animal, have demonstrated that cardiac muscle necrosis is 
associated with inflammatory cascade that clears the infarct 
from dead cells and matrix debris, and then replaces the 
damaged tissue with scar [5].
 Indeed the infarct healing can be divided into three over-
lapping phases: the inflammatory phase, the proliferative 
phase and the maturation phase [5, 6].
 Western blotting, laser confocal microscopy, Raman mi-
croscopy are valuable tools for studying the inflammatory 
response following myocardial infarction, allowing the iden-
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tification and semiquantitative analysis of proteins produced 
during the inflammatory cascade activation and the topog-
raphical distribution and expression of proteins and cells 
involved in myocardial inflammation.  
 Several experimental studies have been conducted to 
quantify the expression of proteins (cytokines, chemokines, 
etc.) and to observe their expression in the tissues, as well as 
the cells involved, contributing to the definition of the in-
flammatory response to myocardial infarction [7].
CONFOCAL LASER SCANNING MICROSCOPY  
 Confocal laser scanning microscopy (CLSM) is a rela-
tively new technique for microscopic imaging. It has found 
wide applications in the biological sciences [8, 9] and can 
also be used in specific fields of forensic investigation, with 
specific regard to ballistics, forensic histopathology and 
toxicological pathology [10].
 Thanks to its non-invasive nature of optical sectioning, 
both on living and fixed cells, enables to obtain images with 
an optimal spatial resolution but without any dramatic altera-
tion of their “architecture”. CLSM provides precious infor-
mation regarding the distribution of a substance in the entire 
volume of the sample (e.g. fragment of tissue or cultured 
cells) and of structural and nonstructural components that 
can emit a luminous signal, either by themselves or by means 
of specific stain, which will emit light when they are hit by a 
laser beam. CLSM also provides information regarding the 
various focal planes of the sample (information about depth).  
 The primary value of CLSM to the forensic scientist is its 
ability to produce optical sections through a 3D specimen, 
e.g. an entire cell or a piece of tissue that, to a good ap-
proximation, contains information from only one focal plane. 
By moving the focal plane of the instrument step by step 
through the depth of the specimen, a series of optical sec-
tions can be recorded [11]. This property of the CLSM is 
fundamental for solving 3D biological problems where in-
formation from regions distant from the plane of focus can 
obscure the image (thick objects). 
 Moreover objects may be viewed in a four-dimensional 
space (4D microscopy, xyzt) via a spatial analysis, repeated 
in time, and then combined with the spectral characterization 
of luminous signals coming from samples under examination 
(five-dimensional, 5D microscopy: xyzt). 
 It allows greater resolution, optical sectioning of the 
sample and three-dimensional reconstruction of the same 
sample [12-16].
WESTERN BLOTTING 
 Western blotting or immunoblotting because an antibody 
is used to specifically detect its antigen was introduced by 
Towbin, et al. in 1979 [17]. It is used to detect the presence 
of a specific protein with antibody-antigen interaction in the 
midst of a complex protein mixture extracted from cells. 
 The western blotting procedure is fairly simple and usu-
ally consists of four separate steps: 1) electrophoretic separa-
tion of protein or of nucleic acid fragments in the sample; 2) 
transfer to and immobilization on paper support; 3) binding 
of analytical probe to the target molecule on paper; 4) and 
visualization of bound probe. Once detected, the target pro-
tein will be visualized as a band on a blotting membrane, X-
ray film, or an imaging system. The specific antibodies to the 
protein under examination are needed for western blotting. 
The sources of these antibodies may be serum samples (for 
example, from patients with known infections), purified 
polyclonal antibody preparations, or monoclonal antibodies. 
In this way the procedure essentially confirms the identity of 
a target protein. As a consequence of the interaction of anti-
body and antigen the target protein (the antigen) when im-
mobilized on a paper support can be identified with antibod-
ies. The mixture containing the protein under investigation is 
first resolved into its components by electrophoresis in poly-
acrylamide gels, and the proteins are then transferred to ni-
trocellulose paper. The primary antibody binds to its target 
protein and is immobilized on the blotting support. The anti-
gen-antibody complex can then be identified with antibodies 
to the primary antibodies, which are labeled with radioactive 
iodine, and can then be visualized by autoradiography. The 
labeling antibody can be removed and the protein studied 
further [18].
 The data produced with a western blot is usually quite 
easy to interpret. In the majority of cases, bands correspond-
ing to the target protein will become visible upon treatment 
of the blot with substrate. Their identity is confirmed by 
comparison to molecular weight markers (for size) and a 
positive control (size and signal). In some cases the data may 
be more complex, showing unexpected sizes, multiple bands, 
or alteration in bands following a particular treatment. When 
data does not match expectations, there may be clues as to 
what should be investigated to determine the reason. Con-
versely, when bands are seen at higher levels than expected, 
this may indicate an actual increase in mass due to glycosy-
lation or multimer formation.  
 The data obtained with western blot are typically re-
garded as semi-quantitative. It indeed provides a relative 
comparison of the levels of proteins, but not an absolute 
measure of the quantity of a specific target protein in a bio-
logical sample. The reason for this is two-fold: first, there 
will be variations in loading and transfer rates between the 
samples in separate lanes and on separate blots that will need 
to be normalized before a more precise comparison can be 
made; second, the signal generated will not be linear across 
the concentration range of samples due to substrate availabil-
ity and linear responsiveness of the detection method. Since 
the signal produced is not linear, it should not be used to 
attach a precise concentration to a particular sample [17, 19-
24]. In any case it represents now a routine technique for 
protein analysis. 
RAMAN MICROSCOPY 
 The Raman spectroscopy is a technique, which enables 
us to discover information on the molecular composition of 
materials, and then to identify their nature. This technique is 
based on the diffusion of a monochromatic radiation incident 
on the surface of an object, which can be absorbed, reflected 
or diffused, and it is an ideal tool for identifying and distin-
guishing between organic and inorganic molecules and crys-
tals. Specifically the theory behind the Raman spectroscopy 
is based on the inelastic scattering of low-intensity, nonde-
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structive laser light by solid, liquid or gas sample. It was 
realized that Raman spectroscopy was a convenient probe of 
the vibrational energy levels within a molecule, which easily 
provides molecular fingerprints. Another unique advantage 
of Raman spectroscopy is it can be used to selectively excite 
a needed portion of the molecule by changing the excitation 
wavelength. On top of that Raman spectroscopy doesn’t re-
quired any sample preparation, samples are not destroyed, 
water bands are usually small and easily subtracted and Ra-
man spectra usually contain sharp bands that are characteris-
tic of the specific molecular bonds in the sample. The inten-
sity of the bands in a Raman spectrum is proportional to the 
concentration of the corresponding molecules and thus can 
be used for quantitative analysis. In biological samples, such 
as cells and tissues, infrared spectra often show broad spec-
tral features which can give information regarding cellular 
components. However, Raman spectra give this information 
as well as more detailed information regarding the constitu-
ents of these specific components allowing good specificity 
for qualitative analysis and for discrimination among similar 
materials. 
 The spectral information in confocal microscopy can be 
obtained through different techniques such as Absorption, 
Reflection, Transmission, Emission, Photoluminescence, 
Fluorescence or Raman spectroscopy. 
 Confocal Raman spectrometers are today relatively 
commonplace in many laboratories undertaking forensic-
related studies [25]. Confocal optics enables both better lat-
eral spatial and depth resolution measurements. The sample 
is mounted on an x-y-= translation stage, where x-y repre-
sents the normal (horizontal) focal plane and z the depth 
(vertical, axial) direction; the sample can be either viewed 
visually, photographed or videoed, or interrogated using 
Raman spectroscopy. The latter depending on the instrumen-
tation may be accomplished either as a single or series (lin-
ear or two-dimensional map) of single point measurements, 
and/or a depth profile, or as a series of images at specific 
wave numbers. For convenience, many micro-samples may 
simply be placed onto a conventional microscope slide sup-
ported on the standard microscope sampling stage. Raman 
spectroscopic imaging sometimes referred to as Raman 
chemical imaging (CI), is used to provide a visual perception 
of specimens that may be spatially heterogeneous in compo-
sition and structure [26]. The term "chemical imaging" is 
often applied to describe molecular or molecular group spe-
cific images generated from measurements by various vibra-
tional spectroscopy techniques [27].
 Confocal Raman microscopy combines the three-
dimensional optical resolution of confocal microscopy and 
the sensitivity to molecular vibrations, which characterizes 
Raman spectroscopy. In confocal Raman microscopy, re-
cording the integrated intensity of characteristic Raman lines 
of the substances involved can image the chemical composi-
tion of a sample. 
THE INFLAMMATORY RESPONSE AFTER MYO-
CARDIAL INFARCTION 
 The inflammatory response involves a humoral phase and 
a cellular phase. Cells dying by necrosis release their intra-
cellular contents (“danger signals”) and initiate an intense 
inflammatory response by activating innate immune mecha-
nisms [28]. Cardiomyocyte death triggers rapid activation of 
the complement cascade, generates free radicals and acti-
vates Toll-Like Receptor (TLR)-mediated pathways [29],
which play a significant role in triggering the post-infarction 
inflammatory response by activating the nuclear factor (NF)-
B system [6]. The activation of NF-B in resident myocar-
dial cells induces expression of cytokines (TNF-alpha, IL-6, 
IL-1), chemokines and adhesion molecules [6, 28, 30]. The 
result is recruitment of neutrophil and monocyte into the 
infarcted area [31, 32]. Chemokines are secreted into the 
subendothelium and are also displayed in the luminal surface 
of endothelial cells, where they bind to chemokine receptors 
expressed by circulating leukocytes [33]. This interaction 
results in integrin-mediated adhesion, followed by diapedesis 
of leukocytes into the subendothelial space [28]. Cells re-
cruitment is regulated by complement activation, release and 
induction of MCP-1 (monocyte chemoattractant protein-1) 
and IL-8. Resident mast cells release preformed histamine 
and TNF-alpha and initiated cytokine cascade, which leads 
to IL-6 synthesis in mononuclear cells and myocytes. The 
myocytes in the ischemic border zone express ICAM-1 (in-
tercellular adhesion molecule-1) and become susceptible to 
neutrophil toxicity [34]. The leukocyte chemotaxis is also 
mediated by reactive oxygen trough complement activation, 
induction of P-selectin expression, chemokine upregulation 
and the increase of the ability of endothelial ICAM-1 to bind 
neutrophils [35-41]. Inside of the infracted area, infiltrating 
leukocytes clear the infarct from dead cells and matrix debris 
and regulate extracellular matrix metabolism and activate 
mesenchymal cells through the induction of cytokines and 
growth factors. TNF-alpha yet expressed at this stage regu-
lates extracellular matrix metabolism by reducing collagen 
synthesis and by enhancing matrix metalloprotease activity 
in cardiac fibroblasts [42, 43]. Macrophages and mast cells 
accumulate in the healing scar and secrete a variety of 
growth factors and cytokines, inducing fibroblast prolifera-
tion. Lymphocytes and a subset of the macrophages produce 
the macrophage-modulating cytokine IL-10, which may have 
a role in suppressing the inflammatory response and in tissue 
remodeling by regulating expression of metalloproteinases 
and their inhibitors [30]. In the healing wound activated 
platelets may play multiple roles by aggregating in areas of 
injury, by contributing to the formation of a fibrin-based 
provisional matrix and by releasing a variety of chemokines 
(such as RANTES and PF4), cytokines (such as IL-1 beta) 
and growth factors (such as platelet-derived growth factor 
(PDGF) and trasformig growth factor-beta (TGF-beta). In 
addition, platelets are capable of initiating complement acti-
vation and may play a role in localizing the inflammatory 
response into the area of injury [6, 44-46].
 At this stage expression of pro-inflammatory mediators is 
suppressed, while fibroblasts and endothelial cells proliferate 
[6]. Inflammatory leukocytes undergo apoptotic death and are 
cleared from the infarcted area; the removal of “corpses” plays 
an important role in the resolution of inflammation by induc-
ing the expression of inhibitory mediators, such as TGF-beta 
and IL-10, which suppress inflammatory cytokine and 
chemokine synthesis [6, 30, 47, 48].
 Fibroblast and endothelial cell proliferation marks the 
transition from the inflammatory to the proliferative phase of 
healing [28].
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HUMORAL PHASE 
 It is known that TNF-alpha suppresses cardiac contrac-
tility [49, 50] and enhances cardiomyocyte apoptosis [51], 
and it is expressed in several pathological conditions [52-55].
Moreover TNF-alpha is upregulated in the myocardium in 
response to transient myocardial ischemia and reperfusion 
[56-58], but it is also expressed chronically after myocardial 
infarction. 
 Indeed TNF-alpha stimulates expression of proinflamma-
tory cytokines, chemokines and adhesion molecules by leu-
kocytes and endothelial cells and regulates extracellular ma-
trix metabolism by reducing collagen synthesis and by en-
hancing MMP (matrix metallo proteinase) activity in cardiac 
fibroblasts [42]. These distinct biological effects are medi-
ated through the two different TNFR1 and TNFR2 receptor 
[6]. The mast cell-derived TNF-alpha rapid release following 
myocardial ischemia, represents the cytokine responsible for 
initiating the inflammatory cascade, but also may induce a 
cytoprotective signal able to preventing or delaying the de-
velopment of myocyte apoptosis following myocardial in-
farction [59].
 IL-1 is consistently induced and activated following tis-
sue injury and plays an essential role in many inflammatory 
conditions [53, 60]. Through activation of the NF-B sys-
tem, IL-1 signaling induces the expression of chemokines, 
pro-inflammatory cytokines [61], adhesion molecules [62], 
colony-stimulating factors, and mesenchymal growth factor 
[28]. In different experimental studies marked IL-1 upregula-
tion has been reported in myocardial infarction [57, 63]. This 
finding is in agreement with the detection of high IL-1 beta 
plasma levels in patients with acute myocardial infarction 
within the first few hours after the onset of chest pain [64]. 
Through the induction of others chemokine by both mono-
nuclear and endothelial cells and adhesion molecule expres-
sion, IL-1 facilitates infiltration of injured tissues by in-
flammatory leukocytes [65, 66]. Moreover IL-1 stimulation 
enhances adhesion molecule expression by endothelial cells 
and activates integrin-mediated pathways facilitating neutro-
phil and mononuclear cell transendothelial migration [67, 
68], and strongly prolongs neutrophil survival by inhibiting 
their apoptotic death [69]. Moreover IL-1 signaling may en-
hance synthesis of other inflammatory mediators promoting 
cytokine-induced cardiomyocyte apoptosis as demonstrated 
by both in vitro and in vivo studies [28, 70]. Finally it may 
increase matrix remodeling of the ventricle, activating prote-
ase-induced matrix degradation, altering MMP expression 
and activity. In addition to its effects on inflammatory cells 
and cardiomyocytes, IL-1 also modulates phenotype and 
gene expression of fibroblasts, the main cells involved in 
reparative responses. IL-1 beta directly enhances fibrous 
tissue deposition by upregulating the expression of angio-
tensin II type 1 receptors on cardiac fibroblasts [71] and by 
stimulating fibroblast migration [72]. These findings sug-
gested that IL-1 signaling is essential for activation of in-
flammatory and fibrogenic pathways in the healing infarct 
and may play an important role in the pathogenesis of post-
infarction remodeling [6, 73]. 
 It is demonstrated that IL-6 was rapidly expressed in the 
ischemic segments and its expression was dependent upon 
reperfusion, such as for ICAM-1 [74, 75]. Activation of the 
inflammatory response in the infracted myocardium is associ-
ated with induction of endothelial adhesion molecules and 
enhanced permeability of the microvasculature. These obser-
vations are consistent with the hypothesis that reperfusion 
initiates a cascade of cytokine-related events leading to IL-6 
expression and subsequent induction of ICAM-1 mRNA in the 
ischemic and reperfused myocardium. IL-6 synthesis is rap-
idly induced in mononuclear cells and cardiomyocytes of the 
ischemic myocardium [76-78], in fact in the border zone of 
myocardial infarcts mononuclear cells and myocytes exhibit 
reperfusion-dependent expression of IL-6 mRNA within 1 h 
after reperfusion [79]. Members of the IL-6 family have pro-
found effects on cardiac myocytes by promoting cardiac hy-
pertrophy, but also by protecting them from apoptosis. TNF-
alpha of mast cell origin may be a crucial factor in upregulat-
ing IL-6 in infiltrating cells and initiating the cytokine cascade 
responsible for myocyte ICAM-1 induction and subsequent 
neutrophil-induced injury [80]. Upregulation of chemokines 
and cytokines results in extravasation of activated blood-
derived cells into the infarcted area [6].
 The mononuclear infiltration of the myocardium in the 
first few hours of reperfusion depends on C5a, TGFbeta1 
and MCP-1. MCP-1 is rapidly upregulated in the venular 
endothelium of ischemic myocardial segments [81, 82] and 
exerts important actions on non-hematopoietic cells, induc-
ing angiogenic and arteriogenic effects [83] and modulating 
fibroblast phenotype and activity by increasing collagen ex-
pression and by regulating MMP synthesis [84]. MCP-1 has 
important effects on macrophage recruitment and activation, 
cytokine synthesis and myofibroblast accumulation in heal-
ing infarcts. Infiltration of monocytes into the infracted myo-
cardium is followed by maturation and differentiation of 
these blood – derived cells into macrophages [43]. Previous 
investigations indicated that MCP-1 induces monocyte IL-1 
[85] and IL-6 synthesis [86] and that it may be involved in 
differentiation of monocytes into foam macrophages [87]. 
MCP-1 may also directly modulate macrophage differentia-
tion, phagocytic activity and cytokine expression [6, 33].
 ICAM-1 is a ligand-specific adhesion of the neutrophils 
to the cardiac myocytes and it is expressed in ischemic myo-
cardial segments. Myocyte ICAM-1 induction could be af-
fected by cytokine IL-1, TNF-alpha and IL-6. ICAM-1 
mRNA expression was detected in much of the reperfused 
viable myocardium by 1 h of reperfusion, adjacent to areas 
of the of contraction band necrosis [88]. After 3 h its expres-
sion occurred in cells in the jeopardized area. The area of 
induction of ICAM-1 mRNA on the viable border zone re-
gion of the infarct is the area where the most intense neutro-
phil margination and infiltration occur [34]. Conversely 
where reperfusion did not occur, ischemic segments did not 
express ICAM-1 mRNA or ICAM-1 protein in areas of oc-
clusion for periods up to 24 h. Therefore the layers of myo-
cardial cells directly adjacent to the endocardium are spared 
injury, conserve glycogen and do not express ICAM-1 
mRNA in early reperfusion. 
 In vitro experiments suggested that the mechanism of 
neutrophil-cardiomyocyte adhesion is dependent not only on 
expression of ICAM-1, but also on CD18 integrin activation 
on neutrophils [89], by injured cardiomyocytes. Integrins are 
a family of heterodimeric membrane glycoproteins that con-
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sist of an alpha and beta subunit. Activation of integrin 
CD18 is required for the firm adhesion of neutrophils. Sta-
tionary neutrophils adherent to the luminal andothelial sur-
face frequently change shape and assume the characteristic 
bipolar configuration of motile cells [90, 91].
 Another important role in neutrophil chemotaxis in the 
infarcted myocardium is determined by the chemokine IL-8 
that may play an important role in granulocyte recruitment in 
the infarcted myocardium and has angiogenic properties in the 
ischemic heart [92]. IL-8 induces the neutrophil respiratory 
burst and granule release, and enhances cellular adhesion. In 
reperfused myocardial infarcts, IL-8 is markedly induced after 
1 h of reperfusion and persists at high levels beyond 24 h [6].
Several studies using antibody neutralization have supported 
an important role for IL-8 in mediating neutrophil – induced 
injury in ischemic and reperfused tissue.  
 Finally, the IL-10, produced by macrophages is the “stop 
signal” to the inflammatory phase. It is a mononuclear cell 
product and modify function, morphology and phenotype of 
monocyte-macrophages and inhibits the production of IL-1 
alpha and beta, TNF-alpha, IL-6, IL-8, suppressing the in-
flammatory response [93, 94]. IL-10 mRNA and protein 
upregulation was demonstrated in the reperfused infarcted 
myocardium using a canine model of myocardial infarction. 
IL-10 expression was first detected at 5 h and peaked follow-
ing 96–120 h of reperfusion. It also regulates extracellular 
matrix metabolism and angiogenesis [48, 94].
CELLULAR PHASE 
 Neutrophils are recruited very early after cardiac injury 
and the selectin family of adhesion molecules mediates their 
transmigration, in the infarcted myocardium. Moreover se-
lectins promote leukocyte attachment and rolling at shear 
stresses characteristic of post-capillary venules [6]. Indeed 
after an inflammatory stimulus, leukocytes roll along the 
post-capillary venules at velocities distinctly below that of 
flowing blood and determine a microvascular obstruction. 
Some rolling cells after stops change shape in apparent re-
sponse to local chemotactic stimuli after a few minutes [34].
Moreover neutrophils may directly injure parenchymal cells 
through release of specific toxic products [95] and may con-
tribute to the healing response through their apoptosis and 
subsequent clearance by macrophages, resulting in resolution 
of inflammation and transition to fibrosis [6].
 Differentiated macrophages play multiple roles in the 
healing infarct. First, they are responsible for phagocytosis 
of dead cells and debris and for clearance of apoptotic neu-
trophils and cardiomyocytes. Second, they serve as a source 
of cytokines and growth factors regulating fibroblast growth 
and angiogenesis. Third, they contribute to extracellular ma-
trix remodeling by producing MMPs and their inhibitors [6].
 Mast cells are multifunctional resident cells, capable of 
secreting a wide range of inflammatory and pro-fibrotic me-
diators. They play a dual role by acting both in the early 
phase and then in the late inflammation. It is demonstrated 
that resident cardiac mast cells rapidly degranulate following 
infarction releasing large amounts of preformed histamine 
and TNF-alpha, modulating the inflammatory response [80]. 
Histamine may induce surface expression of P-selectin in 
endothelial cells, whereas mast cell-derived TNF-alpha 
played an important role in stimulating cytokine expression 
by infiltrating mononuclear cells and regulating adhesion 
molecule expression and leukocyte recruitment. These resi-
dent mast cells are predominantly located in close proximity 
to vessels [96]. 
 In later stages, there is a likely role for mast cells in the 
orchestrated interaction of cells, cytokines, growth factors 
and extracellular matrix proteins mediating myocardial re-
pair and participate in the fibrotic process. Recent studies 
demonstrated that mast cell numbers increase in the healing 
phase of reperfused canine myocardial infarcts [97]. Tryp-
tase released from mast cell granules stimulates granulocyte 
recruitment [98], and upregulates cytokine and chemokine 
synthesis [99, 100] and induces fibroblast proliferation [101] 
and chemotaxis and upregulates type I collagen production 
[102]. Histamine has been shown to stimulate fibroblast 
growth and collagen synthesis in vitro [103]. Furthermore, 
mast cells are important sources of TGF-beta, basic fibro-
blast growth factor (bFGF), and vascular endothelial growth 
factor (VEGF), factors that can regulate fibroblast growth, 
modulate extracellular matrix metabolism and stimulate an-
giogenesis [6, 104-106]. 
 The increase in mast cell density was first noted after 72 
h of reperfusion. Following 5–7 days of reperfusion, mast 
cell numbers in fibrotic areas, in which myocytes were fully 
replaced by scar, were markedly higher than the numbers 
from areas of the same section showing intact myocardium 
[34, 97]. 
PROTEINS AND CELLS IDENTIFICATION AND 
THEIR TOPOGRAPHIC DISTRIBUTION  
 The data reported regarding the production and function 
of numerous cytokines, chemokines, adhesion molecules and 
cells produced in response to myocardial infarction, derived 
mainly from animal and human studies, in vivo and in vitro,
by means of the use of techniques designed to detect the 
mRNA as an index of their expression. 
 Additional data, and not always match, especially as re-
gards the timing of expression of various cytokines, can be 
supplied by research with western blotting of the real pres-
ence of the proteins in the sample examined. 
 ICAM-1 is expressed 1h after reperfusion with marked 
elevations after longer time intervals. These data derived 
using in situ hybridization techniques, which demonstrated 
ICAM-1 RNA expression at 24h mRNA was found in all 
myocardial samples suggesting that circulating cytokines are 
inducing ICAM-1 mRNA in normal as well as in ischemic 
areas. However, when the ICAM-1 protein is searched, it is 
not seen until 3-6 h and is almost exclusively seen in the 
ischemic area at all time points [107].
 In a work of Bujak et al. [73] they studied western blot-
ting protein isolated from infarct and non-infarcted remodel-
ing myocardium of (wild type) and IL1Rl-null hearts after 7 
days of reperfusion, using a goat anti-MMP2 and rat anti 
MMP-3 antibody. They demonstrated that IL-1Rl deficiency 
was associated with reduced MMP-2 and MMP-3 protein 
levels in the infracted myocardium. So the IL-1Rl deficiency 
altered the MMP:TIMP (tissue inibitors of metallo protein-
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ase) expression profile in the infarct and the remote remodel-
ing heart reducing MMP-2 and 3 expression. IL-1 beta di-
rectly enhances fibrous tissue deposition by up-regulating 
expression of angiotensin II type 1 (AT1) receptors on car-
diac fibroblasts [71] and by stimulating fibroblast migration 
[72]. Beyond its proinflammatory and fibrogenic properties, 
IL-1 also promotes extracellular matrix remodeling by en-
hancing cardiac fibroblast MMP expression [42].
 Western blotting was used by Oyamada et al. [108] to 
study chymase, vibronectin and fibronectin protein expres-
sion after acute myocardial ischemia/reperfusion compared 
with non-ischemic myocardial tissue. They demonstrate that 
chymase inhibition plays an important roles in myocardial 
protection through MMP-9, inflammatory markers and the 
eNOS pathway and may attenuate fibrosis induced by acti-
vated chymase after acute myocardial infarction – reperfu-
sion.  
 Kratzschmar et al. (1996) investigated with western blot-
ting the expression of ADAM-15 in rat MI (myocardial in-
farction) and elucidated its possible mechanisms in the 
pathological process of MI. A disintegrin and metalloprote-
ases (ADAMs) are a large family of membrane-bound gly-
coproteins, which consist of prodomain, metalloprotease 
domain, disintegrin domain, cysteine-rich domain, epidermal 
growth factor (EGF)-like domain, transmembrane domain, 
and cytoplasmic domain. It will provide a novel insight into 
the mechanisms, which influence the inflammatory response 
and cardiac remodelling following MI [109, 110].
 As an example of application of the western blotting also 
for the study of cell populations, Hu Y et al. demonstrate for 
the first time that SR-A (scavenger receptor) deletion pro-
motes macrophage polarization toward a skewed M1 pheno-
type after myocardial infarction. Their results suggest that 
SR-A-dependent M1 macrophage polarization may become a 
new therapeutic target for healing and ventricular remodeling 
after MI. Monocytes/macrophages display heterogeneity in 
both mouse and human. In mouse, macrophages can be cate-
gorized into at least two phenotypically and functionally 
distinct subsets, i.e., classically (M1) and alternatively (M2) 
activated macrophages. Priming with interferon-c (IFN-c), 
TNF-alpha, or sub-stimulatory concentrations of lipopoly-
saccharide (LPS) will program macrophages into the M1 
phenotypic state, which is characterized by a strong pro-
inflammatory profile and potent bacterial killing. In contrast, 
exposure to IL-4 or IL-13 generates M2 macrophages, which 
display an attenuated proinflammatory and an enhanced anti-
inflammatory response. Class A scavenger receptor plays a 
key role in the inflammatory response by modulating the 
activity of inflammatory cytokines [111].
 Once demonstrated the presence of proteins (cytokines, 
chemokines, etc.) is important to know the topographical 
distribution, obtaining in this way additional information 
regarding the extension of the inflammatory process in func-
tion of the time stayed from the time of myocardial infarc-
tion.  
 It has been proved that TNF-alpha can be produced by a 
variety of different cell types in the myocardium and in sev-
eral sites. In their work Irwin et al. [56] examined both the 
temporal and spatial expression of TNF-alpha in a chronic 
model of cardiac injury with northern blot analysis and im-
munohistochemistry. They found that TNF-alpha is persis-
tently expressed in the myocardium after infarction, and that 
its expression was not limited to the infarct zone but was 
persistently expressed by myocytes in the controlateral nor-
mal zone, in which myocardial remodeling was ongoing. 
They demonstrated that TNF-alpha upregulation occurs very 
early after myocardial injury released from mast-cells and 
persists in myocytes with time. The fact that TNF-alpha gene 
and protein expression is at a high level in the controlateral 
zone suggests a potential role of the cytokine in the signaling 
process leading to myocardial remodeling.  
 By observation with confocal microscope we studied the 
localization and the intensity of fluorescence in the different 
areas of myocardium of TNF-, IL-1 and IL-6 induced by 
ROS.  
 The preliminary results of our study involving fatal cases 
of myocardial infarction, we observed, using both western 
blotting that the confocal microscope, a different expression 
over time of inflammatory cytokines (IL-1beta, IL-6, IL-8, 
TNF-alpha, MCP-1, ICAM-1, CD18, IL-15), neutrophils and 
mast cells, in the first 12 hours after the onset of myocardial 
infarction (Figs. 1-4). All these cytokines are oversynthesized 
mainly by necrotic cardiomyocytes and activated macrophages 
and neutrophiles in damaged areas. They have direct effects 
on cardiomyocytes and down-regulate sarcoplasmatic reticu-
lum proteins, inhibit contractility and induce apoptosis [53].
Final biological effect of action of cardioinhibitory cytokines 
depends on the degree and duration of their upregulation. Mild 
elevation or even high but short-lasting may be protective, but 
exaggerated and prolonged increase in cardioinhibitory cyto-
kines may lead to irreversible cardiac injury and promote de-
velopment of heart failure [53].
 The induction and release of cytokine such as TNF-alpha 
and IL-6 are rapidly release in the central zone during a 
myocardial infarction; however they are usually maximal in 
the border zone [56, 79].
 Using the double labeling is possible to observe the colo-
calization of cytokines in the myocytes, as the authors have 
done in this paper where they sought to determine whether 
IL-6 modulates myocardial infarction or the late phase of 
preconditioning. Colocalization of IL-6 and troponin T sig-
nals by confocal microscopic examination confirmed the 
cytoplasmic distribution of intracellular IL-6 in cardiomyo-
cytes. IL-6 plays an obligatory role in late preconditioning 
via JAK–STAT signaling (Janus kinase-signal trasducers 
and activators of transcription) and upregulation of iNOS 
and COX-2 (cyclooxygenase) [112].
 The ability to acquire, to keep, to work with images such 
as those obtained with confocal microscopy, to perform 3D 
reconstruction, to produce optical sections of the same sam-
ple, and the excellent definition of the image, using fluores-
cence all provide knowledge and ideas for further research. 
This non-invasive technique also permits characterization, 
localization and qualitative quantification of free ions, mes-
sengers, pH, voltage and other molecules constituting living 
cells [113].
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Fig. (1). (A+B) Confocal laser scanning microscope to observe IL-6 topographic distribution in myocardial infarction (MI): (A) little foci of 
myocardial necrosis (< 6h) with weak perivasal and interstitial IL-6 reaction (green reaction); (B) foci of myocardial necrosis (> 6h) with 
intensive expression of IL-6 by intact myocytes of the border zone (pink reaction). (C) Immunoblot analysis demonstrated the presence of IL-
6, with a molecular weight of approximately 28kDa, obtained from the cardiac tissue. (D) A graphic overview of results based on the light 
intensity and the number of pixels detected. 
Fig. (2). (A) Confocal laser scanning microscope. Strong positive IL-1beta reaction (in blue) of myocytes near foci of myocardial necrosis (> 
6h). (B) Western blotting analysis demonstrated the presence of IL-1beta with a molecular weight of approximately 44kDa, obtained from
cardiac tissue with myocardial infarction lasting more than 6 hours. (C) Confocal laser scanning microscope. Strong positive IL-15 perivasal 
reaction (in blue) of myocytes near foci of myocardial necrosis (> 6h). (D) Immunoblot analysis demonstrated the presence of IL-15, with a 
molecular weight of approximately 15 kDa, obtained from the cardiac tissue and the graphic overview of results based on the light intensity 
and the number of pixels detected, which shows a different intensity between myocardial lasting shorter than 6 hours compared to that of time 
greater than 6 hours. 
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Fig. (3). (A+B) Confocal laser scanning microscope to observe mast cells topographic distribution in myocardial infarction (MI): (A) interstitial 
mast cells (white reaction) in early myocardial infarction (<6h). (B) perivasal degranulated mast cells (green reaction) near foci of myocardial 
necrosis (> 6h). (C) The different subsequent steps of the analysis by western blotting: from the electrophoresis in polyacrylamide gels, the identi-
fication of the band of interest based on of the comparison with the standard of molecular weights, up to the graphics processing. 
Fig. (4). (A+B) Confocal laser scanning microscope to observe TNF-alpha topographic distribution in myocardial infarction (MI): (A) little 
foci of myocardial necrosis (< 6h) with weak TNF-alpha reaction (in green); (B) more extensive intensive expression of TNF-alpha (blue 
reaction) by intact myocytes of the border zone near foci of myocardial necrosis (> 6h). (C) Immunoblot analysis demonstrated the presence 
of TNF-alpha, with a molecular weight of approximately 17kDa, obtained from the cardiac tissue. (D) A graphic overview of results based on 
the light intensity and the number of pixels detected, showing the differences between myocardial lasting shorter than 6 hours compared to 
that of time greater than 6 hours. 
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 Although several studies have suggested a role for mast 
cells in infarct healing, their specific contribution to the cel-
lular events associated with post-infarction inflammation and 
scar formation remains unclear. In fact, many mast cell-
derived mediators can also be secreted by other cell types, 
which are present in the infarcted ventricle (macrophages, 
fibroblasts, and lymphocytes). Two population of mast – 
cells are individuated by Frangogiannis [80] with an histo-
chemical techniques identifying intracytoplasmatic granules: 
“typical” mast cells or connective-tissue–type mast cells, 
which stained with toluidine blue regardless of fixation, and 
“atypical” mast cells or mucosal-type mast cells that exhib-
ited metachromasia only after fixation in Carnoy’s or Mota’s 
fixative. Then with double-labeling studies combining fluo-
rescent immunocytochemistry for TNF- and FITC-avidin 
counterstaining showed granular cytoplasmic TNF- im-
munoreactivity to be confined almost exclusively to FITC-
avidin–labeled mast cells. Mast cells in the ischemic and 
reperfused myocardium showed significant degranulation. In 
contrast, mast cells in normally perfused segments or in con-
trols appeared to be fully granulated. Immunostaining for 
TNF- in ischemic sections after 1 hour of coronary occlu-
sion and 3 hours of reperfusion showed that TNF- im-
munoreactivity was localized predominantly in mast cells. 
Some of the TNF-–positive cells in the ischemic segments 
showed evidence of degranulation, whereas all the mast cells 
in the normally perfused tissue samples appeared to be fully 
granulated. Similar immunohistochemical experiments using 
an antibody to IL-1 demonstrated no IL-1 immunoreactiv-
ity in the control canine heart. No significant IL-1 expres-
sion was noted in the ischemic heart in early reperfusion.  
 Somasundaram et al. [100] examined the time-course of 
mast cell and macrophage infiltration in healing canine in-
farcts using the dual fluorescence for studying of the gran-
ules. They demonstrate that, although macrophages are much 
more numerous than mast cells in the infarcted heart during 
the proliferative phase of healing, mast cell density remains 
elevated in mature infarcts, while the number of macro-
phages significantly decreases. Then identify tryptase and 
chymase activity and demonstrated the presence of tryptase 
and chymase in most canine cardiac mast cells. Mast cells in 
non-infarcted areas of the canine heart were elongated peri-
vascular cells with a high granular content. Mast cells in 
infarcted and non-infarcted segments of the canine heart had 
both alcian blue-positive and safranin-positive granules. 
Mast cells in control and infarcted areas contained both 
chymase and tryptase at all stages of infarct healing.  
 In other studies the ability of the confocal microscope has 
been used to detect the fine structures of myocytes both in 
normal conditions (distribution of structural proteins, Z 
disks, etc.) and especially in the presence of pathological 
alterations (e.g. contraction band necrosis) with imaging 
possibilities that were unthinkable until a few years ago [55, 
114, 115] as well as the ability to visualize intracellular 
Ca2+ deposits [116].
 Li et al. studied the effects of TNF-alpha on calcium 
movement in rat ventricular myocytes. Intracellular free 
Ca2+ concentration was measured with calcium fluorescent 
probe Fluo-3/AM and laser confocal microscope. TNF-alpha 
inhibited I(Ca,L) in rat ventricular myocytes, while increas-
ing the intercellular free Ca2+ level due to the release of 
Ca2+ from intracellular stores. This phenomena indicates 
TNF-alpa must participates in other signal transduction 
gateways to induce intracellular free Ca2+ release from sar-
coplasmic reticulum [117].
 Another important application is represented by meas-
urement of fluorescence intensity in cardiomyocytes, also in 
small well-defined volumes in single cells. This method con-
sents the comparison of fluorescence from different cells for 
the same proteins, with a quantitative method [118].
 Another confocal microscopy studies are conducted to 
detect and identify apoptotic cell in both MI and not-MI, 
using apoptosis detection kit (Tunel). In order to identify 
apoptotic cell type, the sections were double stained for car-
diomyocytes (Troponin T) and macrophage detection. They 
found that apoptotic macrophages were barely detected in 
the acute phase of reperfusion (2.5h-R) whereas they were 
most abundant from 1d-R. In contrast, apoptotic cardiomyo-
cytes were already detected at 2.5h-R. Moreover the progres-
sion of Tunel + cell and infarct size over time shows that 
necrosis stars during ischemia and increases proportional to 
the severity of ischemia whereas apoptosis in triggered dur-
ing reperfusion [7].
 Apoptosis rate may be also assayed by flow cytometry. 
In their work flavoprotein fluorescence was scanned by con-
focal laser microscope to assess the mitochondrial ATP-
sensitive potassium (mitoKATP) channel activity. Wang et
al. found that myocardial cell apoptosis occurs in hy-
poxia/reoxygenation injury, and EPO (erythropoietin) can 
protect rat cardiomyocytes from hypoxia/reoxygenation-
induced apoptosis. The protective effect is partly associated 
with the PKC/mitoKATP (protein kinase C/mithocondrial 
ATP) pathway [119].
 Another study was conducted to study the spatiotemporal 
changes of gap junctions (connexin 43), desmosomes (des-
moplakin), adherens junctions (cadherin) and integrins (beta 
1 integrin) in cardiomyocytes by immunoconfocal micro-
scope at border zone of myocardial infarction in rats. Matsu-
shita and coworkers found that remodeling of gap junctions 
after myocardial infarction is closely related to changes in 
desmosomes and adherens junctions and that remodeling of 
the intercalated disk region at the myocardial interface with 
areas of scar tissue is associated with acquisition of laminin 
and 1-integrin. Moreover the results showing that abnormal 
distribution of cell junctions occurred at both borderline car-
diomyocytes (in contact with scar tissues) and vicinity car-
diomyocytes (not in contact with scar tissues), suggest that 
direct contact with the scar tissue is not essential to cause the 
abnormality, but rather, indirect effects such as ischemia 
may cause the abnormality [3, 120].
 Communication between myocytes, fibroblasts, and en-
dothelial cells, as well as the extracellular matrix, are critical 
in heart composition and function during normal develop-
ment and pathology. It is known that cytokines play a role in 
cell–cell signaling in the heart. Bowers et al. used confocal 
and transmission electron microscopy to observe close rela-
tionships and possible direct communication between these 
cells in vivo. They observed with confocal microscopy a 
close association between cardiac fibroblasts and the capil-
laries of the heart. Indeed, they found that interactions be-
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tween myocytes and cardiac fibroblasts results in increased 
interleukin-6 and tumor necrosis factor- secretion [121].
 Developing a Raman confocal microscope incorporating 
slit-scanning apparatus, on the hypothesis that high-contrast 
imaging is possible by using a high-speed Raman micro-
scope combined with resonance effect, Ogawa et al. tried to 
visualize heart tissue components based on the molecular 
composition without staining. The method of particular line 
illumination and parallel detection system shortened the im-
age acquisition time, from hours to minutes. Spontaneous 
Raman microscopy (SRM) provides specific vibrational sig-
natures of chemical bonds as a spectrum, allowing identifica-
tion of particular molecules without labeling. The Raman 
spectra usually exhibit sharp spectral features based on spe-
cific molecular structures and conformations of tissues. This 
makes SRM very useful for biomedical applications, such as 
quantitative histochemical analysis of atherosclerosis. How-
ever, these Raman spectroscopic studies are not generally 
based on precise tissue imaging. Tissue imaging clarifies the 
distribution of cellular components in tissues, and is indis-
pensable for morphometric analysis of a given tissue. By 
using in this way they show that SRM provides not only 
morphological but also biochemical information regarding 
heart tissue. They found that the Raman spectrum obtained 
from fibrotic tissue was highly consistent with that of pure 
chemical collagen type I. These data are in accordance with 
previous studies, which that have revealed that after myocar-
dial infarction necrotic cardiomyocytes are eventually re-
placed by fibrotic tissues consisting mainly of collagen type I 
[122]. 
 Raman spectroscopy was used for chemical analysis of 
intact human coronary artery and atherosclerotic lesions, to 
study cellular and extracellular components in different stage 
of disease progression [123, 124]. Clear differences in the 
surface biochemical morphology were observed between 
healthy artery wall, early atherosclerotic lesions, and ad-
vanced plaques. In particular, differences in collagen fibril 
structures were noted between early and advanced lesions. 
Such changes in collagen morphology detected by SHG may 
provide a clinical measure for differentiating plaque burden 
[125].
CONCLUSION 
 Inflammatory pathways play an essential role in the 
pathogenesis of adverse remodeling by modulating the quali-
tative characteristics of the scar, altering the composition of 
the extracellular matrix, and mediating fibrous tissue deposi-
tion in the infarct border zone and the non infracted areas 
[29].
 Because timing of anti-inflammatory interventions and 
patient selection will be critical to the success of anti-
inflammatory interventions after myocardial infarction, large 
animal models and advanced imaging technologies will be 
crucial before making the transition to clinical application 
[126]. 
 Although there are numerous studies about the expres-
sion of various cytokines based mainly on mRNA detection 
methods, it becomes necessary to confirm or integrate these 
data by western blotting. Since there is always an exact 
match between the mRNA expression and its transcription 
into protein, it is essential to check the presence of proteins 
in the sample by semi quantitative analysis by western blot-
ting.  
 These methods may be useful to study and define the 
expression of a wide range of inflammatory mediators at 
several different timepoints providing a more detailed analy-
sis of the time course the infarct. 
 As seen some cytokines, chemokines and inflammatory 
cells undergo to quantitative and/or spatial changes after 
myocardial infarction. Such differences are well appreciated 
by microscopic observation of tissue sections stained with 
specific immunohistochemical reactions, or by western blot-
ting able to detect the real presence of the protein in a spe-
cific sample. As demonstrated in some studies, mRNA ex-
pression detected by in situ hybridization techniques, does 
not match the effective presence of the proteins (e.g., ICAM-
1), demonstrating a protein latency expression that should be 
important to consider when evaluating the time of onset of 
myocardial infarction. 
 The combined use of western blotting and confocal mi-
croscope allows detecting the presence of proteins in the 
sample and trying to observe the exact location within the 
tissue, or the topographical distribution of the same.  
 These methods can be used in the post-mortem diagnosis 
of myocardial infarction, providing useful information on the 
expression over time of several cytokines, chemokines and 
cells, and their quantification. This aspect is important in 
considering the fact that although animal models provide 
important information in dissecting pathophysiologic 
mechanisms, their ability to predict the success of a specific 
approach in human patients is limited. The complexity of the 
clinical context cannot be simulated by experimental studies 
the postinfarction inflammatory cascade is dependent on a 
complex network of molecular mediators with pleiotropic 
effects, dictated by contextual factors and by critical spatial 
and temporal variables [127].
 Western blotting, confocal laser scanning microscope are 
useful tools to study the progressive changes occur in viable 
myocardium (myocytes death, inflammatory response, con-
nective tissue changes). Combining Raman imaging and 
other analytical techniques is expected to yield further pow-
erful insight from the data, and can potentially be used as a 
tool for identifying physiological changes related to myocar-
dial infarction. 
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